Simmons & Simmons’ wide-ranging practice encompasses regulatory compliance, M&A and contract negotiation, with a noted expertise in pharmaceutical product liability. The practice is jointly led by experienced partners Jacques-Antoine Robert and Alexandre Regniault. Robert has a high level of experience and knowledge in the pharmaceutical industry, acting for clients in regulatory matters, transactions and disputes. Regniault is a reference for pharmaceutical, medical device and biotech clients across the full range of contentious and non-contentious matters, from licensing negotiations to breach of contract litigation. Ombline Ancelin stands out for her work in competition law, while Simonetta Giordano specialises in joint ventures and commercial contracts.
Legal 500 Editorial commentary
Accolades
Client satisfaction: Lawyer & team quality
Testimonials
Collated independently by Legal 500 research team.
- ‘Jacques-Antoine Robert demonstrates availability, professionalism, attentiveness, support, responsiveness, and a proactive approach.’
- 'Focused on building sustainable long term relationships with clients. This leads to deep relationships and knowing we can count on Simmons & Simmons to be responsive. The targeted learning and information they share with us about our specific sector is also deeply appreciated - they demonstrate an understanding of what is important to us.'
Key clients
- Merck Santé
- Merck Serono
- Servier
- DomusVi
- Rhythm Pharmaceuticals
- Bayer Healthcare
- Cooper Consumer Health
- Eisai
- Amgen
Lawyers
Leading partners
The strongest partners in their field, leading on market-leading deals and endorsed by peers and clients alike.
Practice head
Jacques-Antoine Robert; Alexandre Regniault
Other key lawyers
Ombline Ancelin; Simonetta Giordano